1. Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT/NF-κB pathway.
- Author
-
Tuo P, Zhao R, Li N, Yan S, Yang G, Wang C, Sun J, Sun H, and Wang M
- Subjects
- Animals, Male, Mice, Heart Failure drug therapy, Ventricular Remodeling drug effects, Inflammation drug therapy, Myocytes, Cardiac drug effects, Hypertension drug therapy, Hypertension chemically induced, Disease Models, Animal, Lycoris chemistry, Myocardium, Angiotensin II, Amaryllidaceae Alkaloids pharmacology, NF-kappa B metabolism, Mice, Inbred C57BL, Proto-Oncogene Proteins c-akt metabolism, Phenanthridines pharmacology, Signal Transduction drug effects, Phosphatidylinositol 3-Kinases metabolism
- Abstract
Background: Ang II induces hypertensive heart failure (HF) via hemodynamic and non-hemodynamic actions. Lycorine (LYC) is an alkaloid derived from Lycoris bulbs, and it possesses anti-cardiovascular disease-related activities. Herein, we explored the potential LYC-mediated regulation of Ang II-induced HF., Methods: Over 4 weeks, we established a hypertensive HF mouse model by infusing Ang II into C57BL/6 mice using a micro-osmotic pump. For the final two weeks, mice were administered LYC via intraperitoneal injection. The LYC signaling network was then deduced using RNA sequencing., Results: LYC administration strongly suppressed hypertrophy, myocardial fibrosis, and cardiac inflammation. As a result, it minimized heart dysfunction while causing no changes in blood pressure. The Nuclear Factor kappa B (NF-κB) network/phosphoinositol-3-kinase (PI3K)-protein kinase B (AKT) was found to be a major modulator of LYC-based cardioprotection using RNA sequencing study. We further confirmed that in cultured cardiomyocytes and mouse hearts, LYC reduced the inflammatory response and downregulated the Ang II-induced PI3K-AKT/NF-κB network. Moreover, PI3K-AKT or NF-κB axis depletion in cardiomyocytes completely abrogated the anti-inflammatory activities of LYC., Conclusion: Herein, we demonstrated that LYC safeguarded hearts in Ang II -stimulated mice by suppressing the PI3K-AKT/NF-κB-induced inflammatory responses. Given the evidence mentioned above, LYC is a robust therapeutic agent for hypertensive HF., Competing Interests: Declaration of competing interest The authors declare that they have no conflict of interest., (Copyright © 2024 Elsevier GmbH. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF